Off‐the‐Shelf Synthetic Biodegradable Grafts Transform In Situ into a Living Arteriovenous Fistula in a Large Animal Model
Open Access
- 26 March 2024
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 13 (17) , e2303888
Abstract
Current vascular access options require frequent interventions. In situ tissue engineering (TE) may overcome these limitations by combining the initial success of synthetic grafts with long‐term advantages of autologous vessels by using biodegradable grafts that transform into autologous vascular tissue at the site of implantation. Scaffolds (6 mm‐Ø) made of supramolecular polycarbonate‐bisurea (PC‐BU), with a polycaprolactone (PCL) anti‐kinking‐coil, are implanted between the carotid artery and jugular vein in goats. A subset is bio‐functionalized using bisurea‐modified‐Stromal cell‐derived factor‐1α (SDF1α) derived peptides and ePTFE grafts as controls. Grafts are explanted after 1 and 3 months, and evaluated for material degradation, tissue formation, compliance, and patency. At 3 months, the scaffold is resorbed and replaced by vascular neo‐tissue, including elastin, contractile markers, and endothelial lining. No dilations, ruptures, or aneurysms are observed and grafts are successfully cannulated at termination. SDF‐1α‐peptide‐biofunctionalization does not influence outcomes. Patency is lower in TE grafts (50%) compared to controls (100% patency), predominantly caused by intimal hyperplasia. Rapid remodeling of a synthetic, biodegradable vascular scaffold into a living, compliant arteriovenous fistula is demonstrated in a large animal model. Despite lower patency compared to ePTFE, transformation into autologous and compliant living tissue with self‐healing capacity may have long‐term advantages.Keywords
Funding Information
- Nierstichting (436001003, InSiTeVx)
This publication has 49 references indexed in Scilit:
- A Novel Hybrid Silk Fibroin/Polyurethane Arteriovenous Graft for Hemodialysis: Proof‐of‐Concept Animal Study in an Ovine ModelAdvanced Healthcare Materials, 2020
- Vascular access animal models used in researchAnnals of Anatomy - Anatomischer Anzeiger, 2019
- The degradation and performance of electrospun supramolecular vascular scaffolds examined upon in vitro enzymatic exposureActa Biomaterialia, 2019
- Supramolecular Antifouling Additives for Robust and Efficient Functionalization of Elastomeric Materials: Molecular Design MattersAdvanced Functional Materials, 2018
- In situ heart valve tissue engineering using a bioresorbable elastomeric implant – From material design to 12 months follow-up in sheepBiomaterials, 2017
- Early in-situ cellularization of a supramolecular vascular graft is modified by synthetic stromal cell-derived factor-1α derived peptidesBiomaterials, 2016
- Vascular tissue engineering: from in vitro to in situWIREs Mechanisms of Disease, 2013
- Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement modelBiomaterials, 2012
- The in vivo degradation, absorption and excretion of PCL-based implantBiomaterials, 2006
- A New Animal Model to Study Intimal Hyperplasia in Arteriovenous FistulasJournal of Surgical Research, 1999